Chemomab Therapeutics Ltd ADR (NASDAQ:CMMB) currently has a daily average trading volume of 107.53K but it saw 3146203 shares traded in last market. With a market cap of 16.92M USD, the company’s current market price of $1.19 came falling about -16.20 while comparing to the previous closing price of $1.42. In past 52 weeks, the stock remained buoying in the range of price level as high as $1.58 and as low as $0.42.
Taking a look at 20-day trading activity of Chemomab Therapeutics Ltd ADR (CMMB) gives us an average price of $1.0877, while its current price level is -24.68% below from 52-week high level whereas it is 183.33% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $1.0280 while that of 200 days or SMA-200 reads an average of $0.7537. A closer look into the stock’s movement over the week reveals that its volatility is standing at 20.44% during that period while stretching the period over a month that decreases to 11.25%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 55.36 which implies that the stock is in neutral territory.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Maxim Group which initiated the stock as “Buy” in its note to investors issued on May 13, 2024, recommending a price target of $4 for it. Oppenheimer upgraded its recommendation for the stock as a “Outperform” from “Perform” on May 06, 2024 while assigning a price target of $6. ROTH MKM issued its recommendations for the stock as it resumed the price target for the stock is $7.
Over the week, CMMB’s stock price is moving 5.31% up while it is 16.15% when we observe its performance for the past one month. Year-to-date it is 133.33% up and over the past year, the stock is showing a downside performance of -9.16%.
Currently, Chemomab Therapeutics Ltd ADR’s total number of outstanding shares is 14.20M. Company’s return on investment (ROI) stands at -141.89% and return on equity (ROE) at -93.56%. Stock’s beta reads 0.43. Stock has a price to book (P/B) ratio of 1.27. Its return on asset (ROA) is -72.85% on average.
